Epstein Barr Virus Volume 2 One Herpes Virus: Many Diseases /

Epstein Barr Virus Volume 2 One Herpes Virus: Many Diseases /

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Münz, Christian. (Editor)
Format: eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2015.
Edition:1st ed. 2015.
Series:Current Topics in Microbiology and Immunology, 391
Subjects:
Cancer research.
Immunology.
Virology.
Infectious diseases.
Animal models in research.
Cancer Research.
Infectious Diseases.
Animal Models.
Online Access:https://doi.org/10.1007/978-3-319-22834-1
Table of Contents:
  • Preface
  • EBV latency
  • Chap. 1. EBNA1 - Lori Frappier, University of Toronto, Canada
  • Chap. 2. EBNA2 and its coactivator EBNA-LP - Bettina Kempkes, Helmholtz Center Munich, Germany, and Paul D. Ling, Baylor College of Medicine, Houston, USA
  • Chap. 3. The EBNA3 family: two oncoproteins and a tumour suppressor that are central to the biology of EBV in B cells- Martin J. Allday, Quentin Bazot and Robert E. White, Imperial College London, UK. Chap. 4. The latent membrane protein 1 (LMP1) - Arnd Kieser and Kai R. Sterz, Helmholtz Center Munich, Germany. Chap. 5. Latent membrane protein 2 (LMP2) - Osman Cen and Richard Longnecker, Northwestern University, Chicago, USA. Chap. 6. EBV non-coding RNAs - Rebecca L. Skalsky and Bryan R. Cullen, Duke University, Durham, USA
  • E. Lytic EBV infection
  • 7. Viral entry - Liudmila S. Chesnokova, Ru Jiang1 and Lindsey M. Hutt-Fletcher, Louisiana State University, Shreveport, USA
  • Chap. 8. Epstein Barr virus lytic cycle reactivation - Jessica McKenzie and Ayman El-Guindy, Yale University, New Haven, USA
  • Immune responses to EBV
  • Chap. 9. Innate immune recognition of EBV - Anna Lünemann and David Nadal, University of Zürich, Switzerland and Martin Rowe, University of Birmingham, UK
  • Chap. 10. Epstein-Barr virus specific humoral immune responses in health and disease - Jaap M. Middeldorp, VU Medical Center, Amsterdam, The Netherlands
  • Chap. 11. T cell responses to EBV - Andrew D. Hislop and Graham S. Taylor, University of Birmingham, UK
  • Chap. 12. Immune evasion by Epstein Barr virus - Maaike E. Ressing, Michiel van Gent, Anna M. Gram, Marjolein Hooykaas, Sytse Piersma and Emmanuel Wiertz, Utrecht Medical Center, The Netherlands
  • Animal models of EBV infection
  • Chap. 13. Non-human primate lymphocryptoviruses: past, present, and future- Janine Mühe and Fred Wang, Harvard University, Boston, USA. Chap.14. EBV infection of mice with reconstituted human immune system components - Christian Münz, University of Zürich, Switzerland
  • Therapy of EBV associated diseases
  • Chap. 15. Adoptive T cell immunotherapy - Stephen Gottschalk and Cliona Rooney, Baylor College of Medicine, Houston, USA
  • Chap. 16. The Development of Prophylactic and Therapeutic EBV Vaccines - Corey Smith and Rajiv Khanna, Queensland Institute of Medical Research, Brisbane, Australia
  • Chap. 17. The biology and clinical utility of EBV monitoring in blood- Jennifer Kanakry and Richard Ambinder, Johns Hopkins University, Baltimore, USA
  • Index.

Similar Items